Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the CMC-EWMA Innovation Award for their ultra-thin antimicrobial dressing. An estimated 50 people attended the symposium to discuss the latest cross-border and market expansion issues in the advanced wound care industry.

Dr. Mitchell Sanders, Managing Director of Drug and Device Discovery Lab (3DL) at CMC Consulting Group and host of the symposium, has stated: ”We are honored and very pleased that Imbed Biosciences is the first recipient of this prestigious award. The esteemed panel of technical innovation judges included Dr. Katharina Merz, Head of Innovation Management at Lohmann & Rauscher GmbH & Co. KG, Dr. Jignesh Patel, Global Innovation Director at Mölnlycke, and Dr. Dan Metcalf, Associate Director at ConvaTec. Many thanks to our judges who had a very difficult position to choose from the finalists.”

“I would like to thank CMC Consulting Group, EWMA, all of the fantastic finalists, and esteemed judges for giving Imbed this opportunity to share our microfilm wound dressing technology on this global stage. We are honored to win the 2016 Wound Care Innovation Award and will carry it responsibly by committing to bring this innovative dressing to clinicians in the very near future” said Ankit Agarwal, CEO of Imbed Biosciences Inc.

Award Presentation

(from the left to the right) Bent von Eitzen, Head of Sales, Cap Partner & EWMA Industry Liaison Director, Gary Robinson, Managing Director, Kirchner Group representing Imbed Biosciences Inc., and Dr. Mitchell Sanders, Managing Director of Drug and Device Discovery Lab (3DL), CMC Consulting Group

About Imbed Biosciences

Imbed Biosciences is a privately held medical device company, located in Madison, WI. It is developing next-generation medical devices that can reduce patient pain and costs for the management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes. Company has a portfolio of products in development based on its patent-pending synthetic ultrathin polymeric films platform that present bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and support wound healing. Research efforts at Imbed are in part funded by grants from National Institutes of Health and National Science Foundation. For more information, visit

About CMC Consulting Group

CMC Consulting Group is an international firm providing integrated transaction advisory, management consulting, medical affairs advisory and innovative research to companies in the healthcare and life science industries. Our clients receive the knowledge, expertise and value-added guidance of both a strategy and medical affairs consulting firm and an investment bank combined into one industry specialist. With offices in the United States and throughout Europe, CMC complements global industry knowledge with rich local market insight. For more information, please visit

Media Contact:
Mitchell Sanders
Managing Director Drug & Device Discovery Lab
CMC Consulting Group
+1 (774) 777-5242

Shivani Pandya
Marketing Analyst
CMC Consulting Group
+1 (774) 777-5243